The 16th Annual Congress of the European Association of Urology, held in Munich, scored a new record of participation, with 10,000 urologists and 13,000 total attendees. The Congress addressed the entire spectrum of urological diseases, with special attention on prostate cancer, especially regarding diagnosis and the evaluation and management of the disease. Important news emerged about drug therapies but also about new surgical techniques. Among other diseases discussed, urinary tract cancer was still a dominant topic.
The 16th Annual Congress of the European Association of Urology, held in Munich, scored a new record of participation, with 10,000 urologists and 13,000 total attendees. The Congress addressed the entire spectrum of urological diseases, with special attention on prostate cancer, especially regarding diagnosis and the evaluation and management of the disease. Important news emerged about drug therapies but also about new surgical techniques. Among other diseases discussed, urinary tract cancer was still a dominant topic.
interviste
16th EAU Congress: topics and guidelines
Le novità nella diagnosi precoce del tumore prostatico
Proper use of PSA in early detection of prostate cancer
The range of treatments for erectile dysfunction
Trattamento della disfunzione erettile: novità e conferme
Metastatic Prostate Cancer: efficacy of Combination Therapy
Pelvic pain and appropriate therapies
Radium 233 treatment in De novo Bone Metastase
BPH LUTS: when treating patients with alpha-blockers
Localized prostate cancer: areas of greatest commitment
Detecting prostate cancer with imaging
Fighting urinary tract infections with and without antibiotics
Alpha-blockers, first line of treatment in patients with BPH LUTS
Erus: a validated way of training in robotic surgery
